Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its ...

Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...

Eve Burstein, an analyst from Bernstein, maintained the Buy rating on Thermo Fisher (TMO – Research Report). The associated price target was ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

Thermo Fisher Scientific (NYSE:TMO) traded higher on Thursday after exceeding Street forecasts with its Q4 2024 financials, ...

Morgan Stanley analyst Tejas Savant has maintained their bullish stance on TMO stock, giving a Buy rating yesterday.Invest with Confidence: ...

Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...

Thermo Fisher is a Life Sciences giant with over $42 billion in yearly revenues and 120 thousand employees. Find out why I ...